Search for Clinical Trial Results

Sponsored By

Neoplasm, Residual - 23 Studies Found

Status Study
Active, not recruiting Study Name: Azacitidine (AZA) in Minimal Residual Disease (MRD) Chronic Myeloid Leukemia (CML)
Condition: Leukemia
Date: 2011-10-24
Interventions:
  • Drug: Azacitidine (AZA) Starti
Completed Study Name: Study of Blinatumomab in Patients With B-cell Lineage Acute Lymphocytic Leukemia With Positive Minimal Residual Disease
Condition:
  • Leukemia
  • Acute Lymphocytic Leukemia

Date: 2015-05-26
Interventions:
  • Drug: Blinatumomab In first in
Completed Study Name: Phase II Study of the BiTE® Blinatumomab (MT103) in Patients With Minimal Residual Disease of B-precursor Acute Lymphoblastic Leukemia (ALL)
Condition: Acute Lymphoblastic Leukemia
Date: 2007-11-19
Interventions: Biological: Blinatumomab (MT103) Administered by continuous intravenous (CIV) over 4 weeks per cycle
<<< Previous